Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel
Crossref DOI link: https://doi.org/10.1007/s13577-020-00373-3
Published Online: 2020-05-25
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Zhiliang
Gao, Yu
Hou, Dianchen
Text and Data Mining valid from 2020-05-25
Version of Record valid from 2020-05-25
Article History
Received: 17 October 2019
Accepted: 7 May 2020
First Online: 25 May 2020
Compliance with ethical standards
:
: The authors declare that they have no competing interests.